The data thus far indicate: (i) the tumor-suppressor functions of PKR and OAS, which correlate well with the anti-tumor properties of IL-24 in lung cancer and (ii) that expression of PKR and OAS might be regulated by post-transcriptional (or post-translational) modifications. The gene discussed is EIF2AK2; the disease is lung cancer.